annual cash & cash equivalents:
$104.86M+$33.44M(+46.81%)Summary
- As of today (May 29, 2025), SMMT annual cash & cash equivalents is $104.86 million, with the most recent change of +$33.44 million (+46.81%) on December 31, 2024.
- During the last 3 years, SMMT annual cash & cash equivalents has risen by +$33.07 million (+46.07%).
- SMMT annual cash & cash equivalents is now -69.92% below its all-time high of $348.61 million, reached on December 31, 2022.
Performance
SMMT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$211.53M+$106.66M(+101.72%)Summary
- As of today (May 29, 2025), SMMT quarterly cash & cash equivalents is $211.53 million, with the most recent change of +$106.66 million (+101.72%) on March 31, 2025.
- Over the past year, SMMT quarterly cash & cash equivalents has increased by +$150.23 million (+245.10%).
- SMMT quarterly cash & cash equivalents is now -39.32% below its all-time high of $348.61 million, reached on December 31, 2022.
Performance
SMMT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SMMT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.8% | +245.1% |
| 3 y3 years | +46.1% | +173.1% |
| 5 y5 years | +64.3% | +285.1% |
SMMT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -69.9% | +46.8% | -39.3% | +789.1% |
| 5 y | 5-year | -69.9% | +64.3% | -39.3% | +894.5% |
| alltime | all time | -69.9% | +5548.4% | -39.3% | >+9999.0% |
SMMT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $211.53M(+101.7%) |
| Dec 2024 | $104.86M(+46.8%) | $104.86M(+11.8%) |
| Sep 2024 | - | $93.78M(+229.8%) |
| Jun 2024 | - | $28.43M(-53.6%) |
| Mar 2024 | - | $61.29M(-14.2%) |
| Dec 2023 | $71.42M(-79.5%) | $71.42M(+200.2%) |
| Sep 2023 | - | $23.79M(-43.5%) |
| Jun 2023 | - | $42.12M(-40.7%) |
| Mar 2023 | - | $70.97M(-79.6%) |
| Dec 2022 | $348.61M(+385.6%) | $348.61M(+185.8%) |
| Sep 2022 | - | $121.97M(+112.7%) |
| Jun 2022 | - | $57.34M(-26.0%) |
| Mar 2022 | - | $77.45M(+7.9%) |
| Dec 2021 | $71.79M(+8.1%) | $71.79M(-10.5%) |
| Sep 2021 | - | $80.25M(-22.4%) |
| Jun 2021 | - | $103.39M(+1.2%) |
| Mar 2021 | - | $102.19M(+53.9%) |
| Dec 2020 | $66.42M(+4.0%) | - |
| Dec 2020 | - | $66.42M(+212.3%) |
| Sep 2020 | - | $21.27M(-61.3%) |
| Mar 2020 | - | $54.92M(+213.0%) |
| Dec 2019 | $63.84M(+81.2%) | - |
| Oct 2019 | - | $17.55M(-30.8%) |
| Jul 2019 | - | $25.37M(-30.7%) |
| Apr 2019 | - | $36.61M(+3.9%) |
| Jan 2019 | $35.23M(+23.8%) | - |
| Jan 2019 | - | $35.23M(+112.5%) |
| Oct 2018 | - | $16.58M(-26.3%) |
| Jul 2018 | - | $22.50M(-41.0%) |
| Apr 2018 | - | $38.12M(+34.0%) |
| Jan 2018 | $28.45M(-18.9%) | - |
| Jan 2018 | - | $28.45M(-32.3%) |
| Oct 2017 | - | $42.03M(+13.0%) |
| Jul 2017 | - | $37.18M(+48.5%) |
| Apr 2017 | - | $25.04M(-28.6%) |
| Jan 2017 | $35.08M | - |
| Jan 2017 | - | $35.08M(-17.1%) |
| Oct 2016 | - | $42.29M(+357.5%) |
| Jul 2016 | - | $9.24M(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2016 | - | $14.60M(-37.1%) |
| Jan 2016 | $23.22M(+36.8%) | - |
| Jan 2016 | - | $23.22M(-32.2%) |
| Oct 2015 | - | $34.24M(-17.0%) |
| Jul 2015 | - | $41.24M(-9.1%) |
| Apr 2015 | - | $45.37M(+167.3%) |
| Jan 2015 | $16.97M(+406.9%) | - |
| Jan 2015 | - | $16.97M(-29.3%) |
| Oct 2014 | - | $24.01M(-18.6%) |
| Jul 2014 | - | $29.49M(+780.7%) |
| Jan 2014 | $3.35M(-37.3%) | - |
| Jan 2014 | - | $3.35M(-63.4%) |
| Jul 2013 | - | $9.15M(+71.4%) |
| Jan 2013 | $5.34M(+63.7%) | - |
| Jan 2013 | - | $5.34M(-28.5%) |
| Jul 2012 | - | $7.47M(+129.1%) |
| Jan 2012 | $3.26M(-36.6%) | - |
| Jan 2012 | - | $3.26M(-46.1%) |
| Jul 2011 | - | $6.04M(+17.5%) |
| Jan 2011 | $5.14M(-47.1%) | - |
| Jan 2011 | - | $5.14M(-27.9%) |
| Jul 2010 | - | $7.13M(-26.6%) |
| Jan 2010 | $9.72M(+148.1%) | - |
| Jan 2010 | - | $9.72M(+575.5%) |
| Jul 2009 | - | $1.44M(-63.3%) |
| Jan 2009 | $3.92M(-80.5%) | - |
| Jan 2009 | - | $3.92M(-75.3%) |
| Jul 2008 | - | $15.86M(-21.0%) |
| Jan 2008 | $20.06M(-44.1%) | - |
| Jan 2008 | - | $20.06M(-30.6%) |
| Jul 2007 | - | $28.91M(-19.4%) |
| Jan 2007 | $35.87M(+1832.4%) | - |
| Jan 2007 | - | $35.87M(-5.0%) |
| Jul 2006 | - | $37.77M(+1934.2%) |
| Jan 2006 | $1.86M(-93.0%) | - |
| Jan 2006 | - | $1.86M(-91.8%) |
| Jul 2005 | - | $22.67M(-15.0%) |
| Jan 2005 | $26.66M | - |
| Jan 2005 | - | $26.66M(>+9900.0%) |
| Jul 2004 | - | $176.70K |
FAQ
- What is Summit Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Summit Therapeutics?
- What is Summit Therapeutics annual cash & cash equivalents year-on-year change?
- What is Summit Therapeutics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Summit Therapeutics?
- What is Summit Therapeutics quarterly cash & cash equivalents year-on-year change?
What is Summit Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of SMMT is $104.86M
What is the all time high annual cash & cash equivalents for Summit Therapeutics?
Summit Therapeutics all-time high annual cash & cash equivalents is $348.61M
What is Summit Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, SMMT annual cash & cash equivalents has changed by +$33.44M (+46.81%)
What is Summit Therapeutics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SMMT is $211.53M
What is the all time high quarterly cash & cash equivalents for Summit Therapeutics?
Summit Therapeutics all-time high quarterly cash & cash equivalents is $348.61M
What is Summit Therapeutics quarterly cash & cash equivalents year-on-year change?
Over the past year, SMMT quarterly cash & cash equivalents has changed by +$150.23M (+245.10%)